Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension
Sodium-glucose transporter 2 (SGLT2) inhibitors are new glucose-lowering agents that have been proven to be beneficial for patients with cardiovascular diseases, heart failure, and sudden cardiac death. However, the possible protective effects of cardiac arrhythmia have not yet been clarified in cli...
Main Authors: | Shih-Jie Jhuo, Tsung-Hsien Lin, Yi-Hsiung Lin, Wei-Chung Tsai, I-Hsin Liu, Bin-Nan Wu, Kun-Tai Lee, Wen-Ter Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/2/271 |
Similar Items
-
SGLT2 Inhibitors and Their Antiarrhythmic Properties
by: Ewald Kolesnik, et al.
Published: (2022-01-01) -
Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
by: Jia Liao, et al.
Published: (2024-02-01) -
Dissecting the reduction in cardiovascular death with SGLT2 inhibitors: Potential contribution of effects on ventricular arrhythmias and sudden cardiac death?
by: André J Scheen
Published: (2022-10-01) -
Types and Outcomes of Arrhythmias in a Cardiac Care Unit in Western Kenya: A Prospective Study
by: Joan Kiyeng, et al.
Published: (2023-09-01) -
Surgery for Cardiac Arrhythmias: Past, Present, Future
by: Stephen D. Waterford, et al.
Published: (2024-01-01)